Stephanie Eaton

Stephanie Eaton has extensive experience in quality assurance and quality management within the biopharmaceutical industry. From July 2020 to August 2022, Stephanie served as Senior Director of Site Quality at Lyell Immunopharma and previously held the role of Director of Quality. Prior to this, Stephanie spent nearly six years at Fred Hutch, where roles included Director of Quality and Director of Quality Assurance for the Therapeutic Products Program, alongside a position as Quality Assurance Manager. Earlier career experience includes senior quality assurance roles at CMC Biologics and CMC ICOS Biologics, as well as managerial responsibilities in quality control microbiology at ICOS. Stephanie possesses a Bachelor of Science in Microbiology from the University of Washington, earned in 1998.